Riddhi Siddhi Gluco Biols Limited (BOM:524480)
India · Delayed Price · Currency is INR 710.90
-24.10 (-3.28%)
At close: Oct 1, 2026
Riddhi Siddhi Gluco Biols Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,711 | 2,358 | 1,355 | 2,680 | 1,729 | 2,233 | |
Revenue Growth | -37.97% | 74.04% | -49.43% | 54.96% | -22.55% | -55.13% |
Cost of Revenue | 1,449 | 2,134 | 1,047 | 2,313 | 1,446 | 1,771 |
Gross Profit | 262.13 | 224.09 | 308.3 | 366.98 | 283.66 | 461.6 |
Selling, General & Admin | 84.11 | 106.83 | 112.76 | 103.6 | 91.09 | 63.24 |
Other Operating Expenses | 324.93 | 167.39 | 120.62 | 191.31 | 184.26 | 128.68 |
Operating Expenses | 493.87 | 356.57 | 318.61 | 402.39 | 392.71 | 319.43 |
Operating Income | -231.74 | -132.48 | -10.31 | -35.41 | -109.05 | 142.17 |
Interest Expense | -200.23 | -168.75 | -96.06 | -88.42 | -75.63 | -74.45 |
Interest & Investment Income | - | 566 | 808.7 | 718.14 | 664.26 | 568.41 |
Currency Exchange Gain (Loss) | - | -1.68 | 1.06 | - | -1.45 | -0.92 |
Other Non Operating Income (Expenses) | 644.22 | 33.17 | -0.04 | 7.12 | 0.03 | -0.74 |
EBT Excluding Unusual Items | 212.25 | 296.27 | 703.36 | 601.43 | 478.16 | 634.48 |
Gain (Loss) on Sale of Investments | - | 9.09 | 17.48 | 70.89 | 6.21 | 22.61 |
Gain (Loss) on Sale of Assets | - | - | -6 | -6.85 | - | -14.42 |
Asset Writedown | - | - | - | -18.41 | - | - |
Pretax Income | 212.25 | 305.36 | 714.84 | 647.06 | 484.38 | 642.67 |
Income Tax Expense | 66.06 | 101.49 | 84.32 | 75.19 | 150.5 | 155.51 |
Earnings From Continuing Operations | 146.2 | 203.86 | 630.52 | 571.87 | 333.88 | 487.16 |
Minority Interest in Earnings | -2.72 | -4.83 | -16.12 | -5.28 | -4.85 | 3.72 |
Net Income | 148.96 | 199.04 | 614.4 | 566.6 | 329.03 | 490.87 |
Net Income to Common | 148.96 | 199.04 | 614.4 | 566.6 | 329.03 | 490.87 |
Net Income Growth | -66.90% | -67.61% | 8.44% | 72.20% | -32.97% | - |
Shares Outstanding (Basic) | 7 | 7 | 7 | 7 | 7 | 7 |
Shares Outstanding (Diluted) | 7 | 7 | 7 | 7 | 7 | 7 |
Shares Change | -0.81% | - | - | - | - | - |
EPS (Basic) | 20.59 | 27.92 | 86.17 | 79.47 | 46.15 | 68.85 |
EPS (Diluted) | 20.59 | 27.92 | 86.17 | 79.47 | 46.15 | 68.85 |
EPS Growth | -66.63% | -67.61% | 8.44% | 72.20% | -32.97% | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -95.58 | -769.75 | -44.51 | 2.41 | 1,554 |
Free Cash Flow Per Share | - | -13.40 | -107.96 | -6.24 | 0.34 | 217.96 |
Dividend Per Share | - | 3.000 | 3.000 | 3.000 | 1.500 | 1.000 |
Dividend Growth | - | 0% | 0% | 100.00% | 50.00% | - |
Gross Margin | 15.32% | 9.50% | 22.75% | 13.69% | 16.40% | 20.67% |
Operating Margin | -13.54% | -5.62% | -0.76% | -1.32% | -6.31% | 6.37% |
Profit Margin | 8.71% | 8.44% | 45.34% | 21.14% | 19.03% | 21.98% |
Free Cash Flow Margin | - | -4.05% | -56.80% | -1.66% | 0.14% | 69.59% |
EBITDA | -148.42 | -57.05 | 68.14 | 65.24 | 186.09 | 504.08 |
EBITDA Margin | -8.67% | -2.42% | 5.03% | 2.44% | 10.76% | 22.57% |
D&A For EBITDA | 83.32 | 75.43 | 78.45 | 100.65 | 295.13 | 361.91 |
EBIT | -231.74 | -132.48 | -10.31 | -35.41 | -109.05 | 142.17 |
EBIT Margin | -13.54% | -5.62% | -0.76% | -1.32% | -6.31% | 6.37% |
Effective Tax Rate | 31.12% | 33.24% | 11.80% | 11.62% | 31.07% | 24.20% |
Revenue as Reported | 2,355 | 3,044 | 2,233 | 3,489 | 2,400 | 2,848 |
Advertising Expenses | - | 0.56 | 0.29 | 0.09 | 0.17 | 0.04 |